Supramolecular handcuffs in polymeric architecture
AssigneeCambridge Enterprise Limited
InventorsUrs Rauwald, Oren Alexander Scherman
Life of this patent
Estimating the term…
Abstract
This invention pertains generally to supramolecular polymers comprising a polymeric molecule linked to a first CB[8] guest molecule and an attachment compound linked to a second CB[8] guest molecule, wherein the first and second CB[8] guest molecules form a ternary host-guest complex with a CB[8] molecule which non-covalently links the polymeric molecule and the attachment compound in a supramolecular polymer. These polymers are useful as vehicles for delivery of a therapeutic compound for use in a method of treatment of the human or animal body, in particular for use in a method of delivering the therapeutic compound to a target site in an individual. The invention also provides methods for the preparation of the supramolecular polymers.
Claims26
1-47. (canceled)
A supramolecular polymer comprising a polymeric molecule linked to a first cucurbit[8]uril (CB[8]) guest molecule and an attachment compound linked to a second CB[8] guest molecule,
- wherein the first and second CB[8] guest molecules form a ternary host-guest complex with a CB[8] molecule, or a variant or derivative thereof, which non-covalently links the polymeric molecule and the attachment compound in a supramolecular polymer.
A supramolecular polymer comprising:
- a first polymeric molecule linked to one of a CB[8] molecule, or a variant or derivative thereof, and a ferrocene CB[8] guest molecule, and an attachment compound linked to the other of a CB[8] molecule, or a variant or derivative thereof, and a ferrocene CB[8] guest molecule,
- wherein the ferrocene CB[8] guest molecule and the CB[8] molecule, or a variant or derivative thereof, form a host-guest complex which non-covalently links the first polymeric molecule and the attachment compound in a supramolecular polymer.
The supramolecular polymer according to 48, wherein first polymeric molecule is a hydrophilic polymer selected from (i) the group consisting of polyethylene glycol (PEG) polyvinyl pyrrolidone (PVP), hydroxypropyl methylcellulose (HPMC) polypropylene, polyvinyl alcohol, polyacrylamide and derivatives and copolymers thereof, or (ii) a polypeptide.
A block co-polymer comprising either:
- a first polymeric molecule unit having CB[8] guest molecules at its termini;
- and,
- (a) two units of a second polymeric molecule each having a CB[8] guest molecule at a terminal, or
- (b) two units of a linker molecule each having a CB[8] guest molecule;
- the units of the first and second polymeric molecule, or the units of the first polymeric molecule and the linker molecule, being non-covalently linked by ternary guest-host complexes comprising a CB[8] guest molecule on each unit and a CB[8] molecule, or a variant or derivative thereof;
- or:
- two units of a first polymeric molecule each having a CB[8] guest molecule, or a variant or derivative thereof, at a terminal;
- and,
- (a) a second polymeric molecule unit having CB[8] guest molecules at its termini, or
- (b) a linker molecule unit having CB[8] guest molecules at its termini;
- the units of the first and second polymeric molecule, or the units of the first polymeric molecule and the linker molecule, being non-covalently linked by ternary guest-host complexes comprising a CB[8] guest molecule on each unit and a CB[8] molecule, or a variant or derivative thereof.
An encapsulant comprising a plurality of amphiphilic block co-polymers
- each amphiphilic block co-polymer comprising;
- one or more of units of a hydrophobic polymer having first CB[8] guest molecules at its termini;
- and,
- one or more units of a hydrophilic polymer having second CB[8] guest molecules at its termini,
- the units of the hydrophobic and hydrophilic polymer being non-covalently linked by ternary guest-host complexes comprising the first and second CB[8] guest molecules and a CB[8] molecule, or a variant or derivative thereof,
- wherein said plurality of block co-polymers aggregate to form a micelle or a vesicle in aqueous solution.
A vehicle for delivery of a therapeutic compound comprising:
- a plurality of amphiphilic block co-polymers
- each amphiphilic block co-polymer comprising one or more of units of a hydrophobic polymer having first CB[8] guest molecules at its termini;
- and,
- one or more units of a hydrophilic polymer having second CB[8] guest molecules at its termini,
- the units of the hydrophobic and hydrophilic polymer being non-covalently linked by ternary guest-host complexes comprising the first and second CB[8] guest molecules and a CB[8] molecule, or a variant or derivative thereof,
- said plurality of co-polymers forming a micelle or vesicle, containing a therapeutic compound for delivery.
A method of purifying a target molecule from a sample comprising:
- providing a sample comprising a target molecule linked to a first CB[8] guest molecule,
- contacting the sample with an immobilised first complex comprising a CB[8] molecule, or variant or derivative thereof, and a second CB[8] guest molecule such that the first CB[8] guest molecule interacts with the first complex to form a second complex comprising the CB[8] molecule, or variant or derivative thereof, the first and second CB[8] guest molecules and the target molecule linked to the first CB[8] guest molecule,
- isolating the second complex;
- and,
- releasing the first CB[8] guest molecule linked to the target molecule from the complex,
- the target molecule being purified from the sample.
A method of producing a supramolecular polymer comprising:
- providing a first polymeric molecule linked to a first CB[8] guest molecule and an attachment compound linked to a second CB[8] guest molecule,
- allowing the first and second CB[8] guest molecules to interact with a CB[8] molecule, or a variant or derivative thereof, to form a ternary host-guest complex,
- wherein said complex non-covalently links the polymeric molecule and the attachment compound in a supramolecular polymer.
A method of producing a supramolecular polymer comprising:
- providing a first polymeric molecule linked to one of a CB[8] molecule, or a variant or derivative thereof, and a ferrocene CB[8] guest molecule, and an attachment compound linked to the other of a CB[8] molecule, or a variant or derivative thereof, and a ferrocene CB[8] guest molecule,
- allowing the ferrocene CB[8] guest molecule to interact with the CB[8] molecule, or a variant or derivative thereof, to form a host-guest complex,
- wherein said complex non-covalently links the first polymeric molecule and the attachment compound in a supramolecular polymer.
A method of increasing the solubility of a compound in aqueous solution comprising;
- providing a hydrophilic polymer linked to a first CB[8] guest molecule and a compound linked to a second CB[8] guest molecule,
- allowing the first and second CB[8] guest molecules to interact with a CB[8] molecule, or a variant or derivative thereof, to form a complex
- said complex non-covalently linking the hydrophilic polymer to the compound to form a supramolecular polymer which has increased solubility in aqueous solution relative to the unattached compound.
A method of treatment of the human or animal body, the method comprising administering to a subject a supramolecular polymer comprising a hydrophilic polymer linked to a first CB[8] guest molecule and a therapeutic compound linked to a second CB[8] guest molecule, wherein the first and second CB[8] guest molecules are complexed with a CB[8] molecule, or a variant or derivative thereof, to form the supramolecular polymer comprising the hydrophilic polymer and the therapeutic compound.
A method of producing a block co-polymer comprising either:
- providing a population of first polymeric molecules having CB[8] guest molecules at their termini and (a) a population of second polymeric molecules having a CB[8] guest molecules at a terminal;
- or (b) a population of linker molecules each having a CB[8] guest molecule,
- contacting the populations of (a) first and second polymeric molecules;
- or (b) first polymeric molecules and linker molecules, with a population of CB[8] molecules, or variants or derivatives thereof, such that CB[8] guest molecules, or variants or derivative thereofs, interact with CB[8] molecules to form ternary guest-host complexes,
- thereby producing a block co-polymer comprising (a) a plurality of first and second polymeric molecules non-covalently linked together by said complexes;
- or (b) a plurality of first polymeric molecules and linker molecules non-covalently linked together by said complexes;
- or:
- providing a population of first polymeric molecules each having a CB[8] guest molecule at a terminal and (a) a population of second polymeric molecules each having CB[8] guest molecules at their termini;
- or (b) a population of linker molecules each having CB[8] guest molecules at their termini,
- contacting the populations of (a) first and second polymeric molecules;
- or (b) first polymeric molecules and linker molecules, with a population of CB[8] molecules, or variants or derivatives thereof, such that CB[8] guest molecules, or variants or derivatives thereof, interact with CB[8] molecules to form ternary guest-host complexes,
- thereby producing a block co-polymer comprising (a) a plurality of first and second polymeric molecules non-covalently linked together by said complexes;
- or (b) a plurality of first polymeric molecules and linker molecules non-covalently linked together by said complexes.
Dependencies are inferred from the claim text.